These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 7775622

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
    Larsson H, Ahrén B.
    Diabetes Care; 2000 May; 23(5):650-7. PubMed ID: 10834425
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.
    Larsson H, Ahrén B.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2068-74. PubMed ID: 10372712
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Islet dysfunction in obese women with impaired glucose tolerance.
    Larsson H, Ahrén B.
    Metabolism; 1996 Apr; 45(4):502-9. PubMed ID: 8609839
    [Abstract] [Full Text] [Related]

  • 8. Glucagon secretion in relation to insulin sensitivity in healthy subjects.
    Ahrén B.
    Diabetologia; 2006 Jan; 49(1):117-22. PubMed ID: 16362283
    [Abstract] [Full Text] [Related]

  • 9. Beta- and alpha-cell dysfunction in subjects developing impaired glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women.
    Ahrén B.
    Diabetes; 2009 Mar; 58(3):726-31. PubMed ID: 19095762
    [Abstract] [Full Text] [Related]

  • 10. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
    Stumvoll M, Fritsche A, Stefan N, Hardt E, Häring H.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
    [Abstract] [Full Text] [Related]

  • 11. [Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].
    Tang XF, Li H, Wang JG, Chu SL, Guo JZ, Zhu DL.
    Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):735-9. PubMed ID: 15631823
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
    Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R.
    Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
    [Abstract] [Full Text] [Related]

  • 14. Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance.
    Ahrén B, Pacini G.
    Am J Physiol; 1997 Oct; 273(4):E701-7. PubMed ID: 9357798
    [Abstract] [Full Text] [Related]

  • 15. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [Abstract] [Full Text] [Related]

  • 16. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
    Weyer C, Bogardus C, Pratley RE.
    Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.